Global General Influenza Diagnostics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global General Influenza Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 RIDT
1.2.3 Viral Culture
1.2.4 DFA
1.2.5 Serological Assays
1.3 Market by Application
1.3.1 Global General Influenza Diagnostics Market Share by Application: 2020 VS 2026
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Other End-User
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global General Influenza Diagnostics Market Perspective (2015-2026)
2.2 Global General Influenza Diagnostics Growth Trends by Regions
2.2.1 General Influenza Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 General Influenza Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 General Influenza Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top General Influenza Diagnostics Players by Market Size
3.1.1 Global Top General Influenza Diagnostics Players by Revenue (2015-2020)
3.1.2 Global General Influenza Diagnostics Revenue Market Share by Players (2015-2020)
3.2 Global General Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by General Influenza Diagnostics Revenue
3.4 Global General Influenza Diagnostics Market Concentration Ratio
3.4.1 Global General Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by General Influenza Diagnostics Revenue in 2019
3.5 Key Players General Influenza Diagnostics Area Served
3.6 Key Players General Influenza Diagnostics Product Solution and Service
3.7 Date of Enter into General Influenza Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 General Influenza Diagnostics Breakdown Data by Type (2015-2026)
4.1 Global General Influenza Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global General Influenza Diagnostics Forecasted Market Size by Type (2021-2026)
5 General Influenza Diagnostics Breakdown Data by Application (2015-2026)
5.1 Global General Influenza Diagnostics Historic Market Size by Application (2015-2020)
5.2 Global General Influenza Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America General Influenza Diagnostics Market Size (2015-2026)
6.2 North America General Influenza Diagnostics Market Size by Type (2015-2020)
6.3 North America General Influenza Diagnostics Market Size by Application (2015-2020)
6.4 North America General Influenza Diagnostics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe General Influenza Diagnostics Market Size (2015-2026)
7.2 Europe General Influenza Diagnostics Market Size by Type (2015-2020)
7.3 Europe General Influenza Diagnostics Market Size by Application (2015-2020)
7.4 Europe General Influenza Diagnostics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China General Influenza Diagnostics Market Size (2015-2026)
8.2 China General Influenza Diagnostics Market Size by Type (2015-2020)
8.3 China General Influenza Diagnostics Market Size by Application (2015-2020)
8.4 China General Influenza Diagnostics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan General Influenza Diagnostics Market Size (2015-2026)
9.2 Japan General Influenza Diagnostics Market Size by Type (2015-2020)
9.3 Japan General Influenza Diagnostics Market Size by Application (2015-2020)
9.4 Japan General Influenza Diagnostics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia General Influenza Diagnostics Market Size (2015-2026)
10.2 Southeast Asia General Influenza Diagnostics Market Size by Type (2015-2020)
10.3 Southeast Asia General Influenza Diagnostics Market Size by Application (2015-2020)
10.4 Southeast Asia General Influenza Diagnostics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche General Influenza Diagnostics Introduction
11.1.4 F. Hoffmann-La Roche Revenue in General Influenza Diagnostics Business (2015-2020))
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Quidel Corporation
11.2.1 Quidel Corporation Company Details
11.2.2 Quidel Corporation Business Overview
11.2.3 Quidel Corporation General Influenza Diagnostics Introduction
11.2.4 Quidel Corporation Revenue in General Influenza Diagnostics Business (2015-2020)
11.2.5 Quidel Corporation Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific General Influenza Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Revenue in General Influenza Diagnostics Business (2015-2020)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories General Influenza Diagnostics Introduction
11.4.4 Abbott Laboratories Revenue in General Influenza Diagnostics Business (2015-2020)
11.4.5 Abbott Laboratories Recent Development
11.5 Becton, Dickinson, and Company
11.5.1 Becton, Dickinson, and Company Company Details
11.5.2 Becton, Dickinson, and Company Business Overview
11.5.3 Becton, Dickinson, and Company General Influenza Diagnostics Introduction
11.5.4 Becton, Dickinson, and Company Revenue in General Influenza Diagnostics Business (2015-2020)
11.5.5 Becton, Dickinson, and Company Recent Development
11.6 DiaSorin
11.6.1 DiaSorin Company Details
11.6.2 DiaSorin Business Overview
11.6.3 DiaSorin General Influenza Diagnostics Introduction
11.6.4 DiaSorin Revenue in General Influenza Diagnostics Business (2015-2020)
11.6.5 DiaSorin Recent Development
11.7 bioMérieux
11.7.1 bioMérieux Company Details
11.7.2 bioMérieux Business Overview
11.7.3 bioMérieux General Influenza Diagnostics Introduction
11.7.4 bioMérieux Revenue in General Influenza Diagnostics Business (2015-2020)
11.7.5 bioMérieux Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global General Influenza Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of RIDT
Table 4. Key Players of Viral Culture
Table 5. Key Players of DFA
Table 6. Key Players of Serological Assays
Table 7. Global General Influenza Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global General Influenza Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global General Influenza Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global General Influenza Diagnostics Market Share by Regions (2015-2020)
Table 11. Global General Influenza Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global General Influenza Diagnostics Market Share by Regions (2021-2026)
Table 13. General Influenza Diagnostics Market Market Trends
Table 14. General Influenza Diagnostics Market Drivers
Table 15. General Influenza Diagnostics Market Challenges
Table 16. General Influenza Diagnostics Market Restraints
Table 17. Global General Influenza Diagnostics Revenue by Players (2015-2020) (US$ Million)
Table 18. Global General Influenza Diagnostics Market Share by Players (2015-2020)
Table 19. Global Top General Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Influenza Diagnostics as of 2019)
Table 20. Global General Influenza Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players General Influenza Diagnostics Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global General Influenza Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 25. Global General Influenza Diagnostics Market Size Share by Type (2015-2020)
Table 26. Global General Influenza Diagnostics Revenue Market Share by Type (2021-2026)
Table 27. Global General Influenza Diagnostics Market Size Share by Application (2015-2020)
Table 28. Global General Influenza Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 29. Global General Influenza Diagnostics Market Size Share by Application (2021-2026)
Table 30. North America General Influenza Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 31. North America General Influenza Diagnostics Market Share by Type (2015-2020)
Table 32. North America General Influenza Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 33. North America General Influenza Diagnostics Market Share by Application (2015-2020)
Table 34. North America General Influenza Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 35. North America General Influenza Diagnostics Market Share by Country (2015-2020)
Table 36. Europe General Influenza Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe General Influenza Diagnostics Market Share by Type (2015-2020)
Table 38. Europe General Influenza Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe General Influenza Diagnostics Market Share by Application (2015-2020)
Table 40. Europe General Influenza Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe General Influenza Diagnostics Market Share by Country (2015-2020)
Table 42. China General Influenza Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 43. China General Influenza Diagnostics Market Share by Type (2015-2020)
Table 44. China General Influenza Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 45. China General Influenza Diagnostics Market Share by Application (2015-2020)
Table 46. China General Influenza Diagnostics Market Size by Region (US$ Million) (2015-2020)
Table 47. China General Influenza Diagnostics Market Share by Region (2015-2020)
Table 48. Japan General Influenza Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan General Influenza Diagnostics Market Share by Type (2015-2020)
Table 50. Japan General Influenza Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan General Influenza Diagnostics Market Share by Application (2015-2020)
Table 52. Japan General Influenza Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan General Influenza Diagnostics Market Share by Country (2015-2020)
Table 54. Southeast Asia General Influenza Diagnostics Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia General Influenza Diagnostics Market Share by Type (2015-2020)
Table 56. Southeast Asia General Influenza Diagnostics Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia General Influenza Diagnostics Market Share by Application (2015-2020)
Table 58. Southeast Asia General Influenza Diagnostics Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia General Influenza Diagnostics Market Share by Country (2015-2020)
Table 60. F. Hoffmann-La Roche Company Details
Table 61. F. Hoffmann-La Roche Business Overview
Table 62. F. Hoffmann-La Roche Product
Table 63. F. Hoffmann-La Roche Revenue in General Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 64. F. Hoffmann-La Roche Recent Development
Table 65. Quidel Corporation Company Details
Table 66. Quidel Corporation Business Overview
Table 67. Quidel Corporation Product
Table 68. Quidel Corporation Revenue in General Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 69. Quidel Corporation Recent Development
Table 70. Thermo Fisher Scientific Company Details
Table 71. Thermo Fisher Scientific Business Overview
Table 72. Thermo Fisher Scientific Product
Table 73. Thermo Fisher Scientific Revenue in General Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 74. Thermo Fisher Scientific Recent Development
Table 75. Abbott Laboratories Company Details
Table 76. Abbott Laboratories Business Overview
Table 77. Abbott Laboratories Product
Table 78. Abbott Laboratories Revenue in General Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 79. Abbott Laboratories Recent Development
Table 80. Becton, Dickinson, and Company Company Details
Table 81. Becton, Dickinson, and Company Business Overview
Table 82. Becton, Dickinson, and Company Product
Table 83. Becton, Dickinson, and Company Revenue in General Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 84. Becton, Dickinson, and Company Recent Development
Table 85. DiaSorin Company Details
Table 86. DiaSorin Business Overview
Table 87. DiaSorin Product
Table 88. DiaSorin Revenue in General Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 89. DiaSorin Recent Development
Table 90. bioMérieux Company Details
Table 91. bioMérieux Business Overview
Table 92. bioMérieux Product
Table 93. bioMérieux Revenue in General Influenza Diagnostics Business (2015-2020) (US$ Million)
Table 94. bioMérieux Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of FiguresFigure 1. Global General Influenza Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. RIDT Features
Figure 3. Viral Culture Features
Figure 4. DFA Features
Figure 5. Serological Assays Features
Figure 6. Global General Influenza Diagnostics Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinical Laboratories Case Studies
Figure 9. Other End-User Case Studies
Figure 10. General Influenza Diagnostics Report Years Considered
Figure 11. Global General Influenza Diagnostics Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global General Influenza Diagnostics Market Share by Regions: 2020 VS 2026
Figure 13. Global General Influenza Diagnostics Market Share by Regions (2021-2026)
Figure 14. Global General Influenza Diagnostics Market Share by Players in 2019
Figure 15. Global Top General Influenza Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Influenza Diagnostics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by General Influenza Diagnostics Revenue in 2019
Figure 17. North America General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa General Influenza Diagnostics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. F. Hoffmann-La Roche Revenue Growth Rate in General Influenza Diagnostics Business (2015-2020)
Figure 45. Quidel Corporation Revenue Growth Rate in General Influenza Diagnostics Business (2015-2020)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in General Influenza Diagnostics Business (2015-2020)
Figure 47. Abbott Laboratories Revenue Growth Rate in General Influenza Diagnostics Business (2015-2020)
Figure 48. Becton, Dickinson, and Company Revenue Growth Rate in General Influenza Diagnostics Business (2015-2020)
Figure 49. DiaSorin Revenue Growth Rate in General Influenza Diagnostics Business (2015-2020)
Figure 50. bioMérieux Revenue Growth Rate in General Influenza Diagnostics Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed